News
In this video, Paolo F. Caimi, MD, MBA, staff physician at Cleveland Clinic, discusses KITE-363, an anti-CD19/CD20 chimeric antigen receptor T-cell therapy, being studied for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback